{"disease":{"id":"chronic-lymphoproliferative-disease","name":"chronic lymphoproliferative disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00039676","title":"Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1836,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05978141","title":"A Registry for People With T-cell Lymphoma","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT05032313","title":"Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer","phase":"","overall_status":"COMPLETED","enrollment_count":371,"lead_sponsor_name":"Becton, Dickinson and Company","has_results":false},{"nct_id":"NCT05557422","title":"BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.","phase":"","overall_status":"COMPLETED","enrollment_count":322,"lead_sponsor_name":"Becton, Dickinson and Company","has_results":false},{"nct_id":"NCT06893640","title":"Cell Population Data in CLPD and Viral Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":177,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}